CXCR2 and neoplasm: Furthermore, synergy of CXCR2 and anti-PD-1 inhibition led to the expansion of an intratumoural immature neutrophil population originating from either a neutrophil progenitor (NeP) or tumour-seeded hematopoietic stem cell.